Anbio Biotechnology (NASDAQ:NNNN) Shares Down 3.3% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN)’s share price dropped 3.3% on Thursday . The stock traded as low as $5.32 and last traded at $5.3940. 47,724 shares changed hands during trading, a decline of 35% from the average session volume of 72,946 shares. The stock had previously closed at $5.58.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Anbio Biotechnology Stock Down 1.6%

The business has a 50 day simple moving average of $8.63 and a 200-day simple moving average of $18.30.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.